Cargando…
Factors for the Variability of Three Acceptable Maximal Expiratory Flow–Volume Curves in Chronic Obstructive Pulmonary Disease
BACKGROUND: Generally, the maximal expiratory flow–volume (MEFV) curve must be measured for the diagnosis and staging of chronic obstructive pulmonary disease (COPD). As this test is effort dependent, international guidelines recommend that three acceptable trials are required for each test. However...
Autores principales: | Yamamoto, Masafumi, Konno, Satoshi, Makita, Hironi, Nitta, Katsuaki, Shimizu, Kaoruko, Suzuki, Masaru, Nishida, Mutsumi, Sugita, Junichi, Teshima, Takanori, Nishimura, Masaharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917354/ https://www.ncbi.nlm.nih.gov/pubmed/33658773 http://dx.doi.org/10.2147/COPD.S285086 |
Ejemplares similares
-
Effect of Lung Volume on Airway Luminal Area Assessed by Computed Tomography in Chronic Obstructive Pulmonary Disease
por: Kambara, Kenta, et al.
Publicado: (2014) -
Annual Fractional Exhaled Nitric Oxide Measurements and Exacerbations in Severe Asthma
por: Abe, Yuki, et al.
Publicado: (2020) -
One‐year clinically important deterioration and long‐term clinical course in Japanese patients with COPD: a multicenter observational cohort study
por: Abe, Yuki, et al.
Publicado: (2021) -
Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients
por: Nagai, Katsura, et al.
Publicado: (2015) -
Serum Alpha-1 Antitrypsin Levels and the Clinical Course of Chronic Obstructive Pulmonary Disease
por: Takei, Nozomu, et al.
Publicado: (2019)